A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 360 participants.

Also called NCT07205328

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 360 participants (enrolled count) (from the registry)
Sponsor
Shaanxi Micot Pharmaceutical Technology Co., Ltd. (from the registry)
Registry
  • NCT NCT07205328
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT07205328. Randomized; quadruple masking; primary purpose treatment. Start 2025-09-30 (actual); primary completion 2026-06-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke
Condition
Acute Ischemic Stroke
Intervention (Drug)
MT200605
Intervention (Drug)
MT200605
Intervention (Drug)
MT200605
Intervention (Drug)
Placebo
Lead sponsor
Shaanxi Micot Pharmaceutical Technology Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct07205328
Content hash
b193f4beb7586626dcc99520344dcda83930d8cb5da993f0e7be8182c5162ecd